Background: The majority of cancer patients with malignant fungating wounds
experience wound-related pain, which significantly affects their quality of life.
Despite the clinical relevance of pain in cancer and palliative
care settings, there is limited evidence regarding the availability and
effectiveness of topical treatments for pain management in this population.